Fitch Ratings has upgraded the credit rating of Waystar, the healthcare payments technology firm, citing expectations of lower leverage in the coming periods. The agency announced the upgrade on 21 July 2026, noting that the company's debt reduction strategy and operational improvements have strengthened its financial profile.
According to Fitch, Waystar's leverage is projected to decline as the company generates stronger free cash flow and maintains disciplined capital allocation. The upgrade places Waystar on a more favourable footing within the healthcare IT sector, which has seen increased scrutiny over debt levels amid rising interest rates.
The rating action comes as Waystar continues to integrate recent acquisitions and expand its platform for healthcare revenue cycle management. Analysts suggest the upgrade could lower the company's borrowing costs and enhance its ability to pursue further growth initiatives without straining its balance sheet.
For UK investors with exposure to global healthcare technology through diversified funds or pension portfolios, the upgrade signals a reduced risk profile for Waystar's debt instruments. However, the broader market remains cautious about valuations in the sector, with the FTSE 100 trading relatively flat on the day amid mixed economic data.
Fitch's decision reflects a broader trend of rating agencies reassessing technology-driven healthcare firms as they mature and prioritise profitability over rapid expansion. Waystar's improved credit standing may also support its competitive position against larger rivals in the payments processing space.